tag:blogger.com,1999:blog-4241416962008169508.post721982620388550662..comments2024-03-27T21:03:58.972-04:00Comments on Just A Life Sciences Blog...: Compare & Contrast: CEO Frazier Sees "Flexibilty" To Do "Bolt-On" M&A Of $10B to $20B, In 2016 Unknownnoreply@blogger.comBlogger4125tag:blogger.com,1999:blog-4241416962008169508.post-12070096121771677022016-02-03T13:55:40.805-05:002016-02-03T13:55:40.805-05:00Ahem. Maybe the Anon. Commenter above meant BeiGen...Ahem. Maybe the Anon. Commenter above meant <a href="http://www.sec.gov/Archives/edgar/data/310158/000110465916093324/xslF345X02/a3.xml" rel="nofollow">BeiGene, Ltd</a>:<br /><br />". . .<a href="http://www.sec.gov/Archives/edgar/data/1651308/000104746916009959/a2227215zs-1a.htm#ec44101_business" rel="nofollow"><i>BeiGene is a globally focused biopharmaceutical company</i></a> dedicated to becoming a leader in the discovery and development of innovative, molecularly targeted and immuno-oncology drugs for the treatment of cancer. BeiGene believes the next generation of cancer treatment will utilize therapeutics both as monotherapy and in combination to attack multiple underlying mechanisms of cancer cell growth and survival. BeiGene further believes that discovery of next-generation cancer therapies requires new research tools. To that end, BeiGene has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support our drug discovery effort. . . ."<br /><br />Interesting -- Merck is in now, for over 10 per cent of the outstandings. We will track it.<br /><br />Namaste!Condorhttp://www.shearlingsplowed.blogspot.comnoreply@blogger.comtag:blogger.com,1999:blog-4241416962008169508.post-66264205983752302162016-02-02T03:54:04.860-05:002016-02-02T03:54:04.860-05:00Targets? Nasdaq-listed Benitec BiopharmaTargets? Nasdaq-listed Benitec BiopharmaAnonymousnoreply@blogger.comtag:blogger.com,1999:blog-4241416962008169508.post-26509002018549535032016-01-26T09:04:31.599-05:002016-01-26T09:04:31.599-05:00Hmmm. I employ only public information here Anon.,...Hmmm. I employ only public information here Anon., so mine would be pure guesses.<br /><br />I do expect immuno-oncology to be a continuing focus.<br /><br />That said, if I could pick 'em, I'd be on Wall Street. . . Not here.<br />Thanks! And do stop back. . .<br /><br /> -- NamasteCondorhttp://www.shearlingsplowed.blogspot.comnoreply@blogger.comtag:blogger.com,1999:blog-4241416962008169508.post-49827447692770518602016-01-25T20:00:38.080-05:002016-01-25T20:00:38.080-05:00Any thoughts on potential targets?Any thoughts on potential targets?Anonymousnoreply@blogger.com